Global Coldchain DHL Express operates a vast international logistics network across more than 220 countries and territories, with ongoing investments in temperature-controlled and healthcare logistics facilities in Singapore. This indicates a strong opportunity to upsell advanced cold chain management, pharma and vaccine supply chain solutions, and temperature monitoring technologies to support expanding healthcare and life sciences customers.

Healthcare Expansion Recent and planned investments in pharma hubs, healthcare facilities, and controlled-ambient spaces signal a growing focus on life sciences logistics. This presents a sales opening for specialized regulatory-compliant storage, ambient and cold-chain handling, and integrated serialization/tracking solutions for pharma and biotech clients.

SME Financing DHL Group is pursuing tailored banking and logistics solutions for SMEs engaged in cross-border trade, including greener logistics. This creates cross-sell opportunities for trade finance, integrated logistics, and sustainability-focused financing and advisory services to SME exporters and importers.

Sustainability PUSH GoGreen Plus participation and ongoing green logistics initiatives highlight a buyer segment prioritizing sustainable supply chains. There is potential to offer carbon accounting, emissions reporting, and sustainability-focused logistics optimization services to customers aiming to reduce environmental impact.

Strategic Partnerships Collaborations with GS Caltex, Life Science Incubator, Absa, and other entities point to a network of potential co-sell and alliance opportunities. Positioning as a partner for integrated logistics, regulatory-compliant healthcare handling, and cross-border trade solutions can unlock collaborative growth with customers in energy, life sciences, and manufacturing sectors.